SARAH LADE: Open Payments
NPI 1275027658 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 19 payments from 11 companies in 2025. Trend: 2023 $210 · 2024 $181 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| Amgen Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Impulse Dynamics (USA) Inc. | 1 | $27 |
| BridgeBio Pharma, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
Products named: CAMZYOS, ONPATTRO, REPATHA, Optimizer, Attruby, JARDIANCE, AMVUTTRA, ELIQUIS.
Industry payments across NE — which companies pay providers there.
